Stephen Hoge

Dr. Stephen Hoge is the president of Moderna, a biotechnology company renowned for its development of mRNA vaccines, including those for COVID-19. He has been an advocate for the potential of mRNA technology to transform vaccine development, particularly for flu and other infectious diseases. Recently, he was in the news regarding the FDA's refusal to review Moderna's application for an mRNA seasonal flu vaccine, which he argued was inconsistent with previous communications from the agency.